Nigeria to resume COVID vaccinations on Aug. 16

PUBLISHED: Wed, 11 Aug 2021 07:35:17 GMT
Camillus Eboh
Reuters
Share
A medical worker injects the AstraZeneca’s coronavirus disease (COVID-19) vaccine to a woman at the Nationa Hospital in Abuja, Nigeria March 31, 2021. REUTERS/Afolabi Sotunde/File Photo

ABUJA, Aug 10 (Reuters) – Nigeria will restart COVID-19 inoculations on Aug. 16 after taking delivery of 4 million doses of Moderna vaccine, with shipments of Johnson & Johnson shots also due imminently, the head of the primary healthcare agency said on Tuesday.

Nigeria has so far vaccinated only a tiny fraction of its population of 200 million, largely due to a lack of supply. The latest data, in June, showed that 2 million people had received one dose and 700,000 had received two.

The rollout of vaccines was halted on July 9 because supplies had run out.

Read more: Africa needs at least 20 million Covid vaccine doses in the next six weeks, WHO says

The Moderna doses, which arrived in Nigeria from the United States last week, were being prepared for rollout, said Faisal Shuaib, executive director of the National Primary Healthcare Development Agency.

In particular, he said labels with barcodes were being prepared that would allow for efficient record-keeping of administered doses.

“We want to call on all Nigerians to remain assured that the vaccines that we have are safe and will be deployed next week,” Shuaib told reporters.

Read more: Just give us the vaccines, WHO pleads, as poor countries go wanting

Since the start of the pandemic, Nigeria has recorded about 175,000 cases of COVID-19 and over 2,000 deaths, but the real figures could be much higher as testing is patchy.

The highly contagious Delta variant has recently been detected in the country and authorities have warned infections are rising.

(Reporting by Camillus Eboh, writing by Estelle Shirbon, editing by Giles Elgood)

Sign Up for Our Newsletter Daily Update
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.